COmparison of White Light and Linked COlor Imaging for Detection of RIght COlon Polyps
NCT ID: NCT04112563
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
686 participants
INTERVENTIONAL
2020-01-01
2022-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Experience and Enhancement: Improving Colonoscopic Polyp Detection
NCT00237276
Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection
NCT06216405
Ambient Lighting During Colonoscopy and Its Effect on Adenoma Detection Rate and Eye Fatigue
NCT04441242
Detection of Colorectal Adenoma by Optical Enhancement Technology vs. High-Definition Colonoscopy
NCT02865382
Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.
NCT00436514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A- Inclusion criteria:
1. Patient consecutively admitted to one of the endoscopy units for routine colonoscopy (screening, positive FIT, personal or family history of polyp or cancer, symptoms)
2. Patient whose age is greater than or equal to 18 years and less than 90 years
3. Score: ASA 1, ASA 2, ASA 3
4. No participation in another clinical study
5. Signed informed consent
Exclusion criteria:
History of recto-colic resection Inadequate preparation (none under Boston score \<2) Patient referred for resection of a polyp in place, known IBD (inflammatory bowel disease) or known polyposis
B- Exclusion criteria:
1. History of recto-colonic resection
2. Inadequate preparation (none under Boston score \<2)
3. Patient referred for resection of a known polyp
4. Inflammatory Bowel Disease
5. family polyposis
6. Score: ASA 4, ASA 5
7. Pregnant woman
8. Patient with coagulation abnormalities preventing polyp resection: TP \<50%, Platelets \<50000 / mm3, effective anticoagulation in progress, clopidogrel in progress
9. Patient unable to personally consent
10. No signed informed consent
Purposes of the study:
Compare, when exploring the number of adenomas missed by the first exploration of the right colon by LCI or by white light, according to the order of randomization.
Evaluation criteria :
Main criterion:
\- Missed right colon adenomas by first exploration in LCI-WLI and WLI-LCI groups
Secondary criteria
* Rate of polyps missed by the first exploration
* Serrated polyp rate missed by the first exploration
* Advanced adenoma rate missed by the first exploration
* Comparison of ADR, SPDR, given by the first exploration technique decided by randomization
Number of patients:
The expected rate of "missed adenomas" of the colon is about 20%, based on published data. Considering as relevant an 8% reduction in this rate of "missed adenomas" of the right colon by the LCI, the expected rate for LCI is therefore 12%.
With a risk of the first species of 5% (bilateral test), a power of 80%, 329 patients per group should be included in the study. Taking into account the rate lost to follow-up of 5%, we expect a total of 700 patients.
Duration of the study:
1-2 years
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WLI-LCI group
a first exploration of the right colon will be done in white light (WLI) then a second exploration will be done in LCI
exploration in white light (WLI)
Exploration of the right colon done in white light (WLI)
Exploration in LCI
Exploration of the right colon in linked color imaging (LCI)
LCI-WLI group
a first exploration of the right colon will be done in LCI and a second exploration will be done in white light (WLI)
exploration in white light (WLI)
Exploration of the right colon done in white light (WLI)
Exploration in LCI
Exploration of the right colon in linked color imaging (LCI)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exploration in white light (WLI)
Exploration of the right colon done in white light (WLI)
Exploration in LCI
Exploration of the right colon in linked color imaging (LCI)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inadequate preparation (none under Boston score \<2)
* Patient referred for resection of a known polyp
* known Inflammatory Bowel Disease (IBD) or known polyposis
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société Française d'Endoscopie Digestive
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KARSENTI
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David KARSENTI, MD
Role: PRINCIPAL_INVESTIGATOR
Société Française d'Endoscopie Digestive
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Paris-Bercy
Charenton-le-Pont, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB 2019-A01287-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.